http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006051797-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006051797-A1 |
| titleOfInvention | Treatment for interstitial cystitis |
| abstract | The following general formula (I) [Chemical 1] (In the formula, R 1 represents a hydroxyl group or a lower alkoxy group.) A therapeutic agent for interstitial cystitis comprising a phenoxyacetic acid derivative represented by the formula: or a pharmacologically acceptable salt thereof. The phenoxyacetic acid derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof has a selective β 3 -adrenoceptor stimulating action and significant capsaicin sensitivity perception. Because it has a neurological inhibitory effect, painful interstitial cystitis, overactive bladder, other diseases involving capsaicin-sensitive sensory nerves (eg, acute and chronic systemic and local pain and inflammation) and hypersensitivity It can be used as a prophylactic or therapeutic agent for sexual bowel syndrome (IBS). |
| priorityDate | 2004-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.